0
Skip to Content
Context Therapeutics
About
Pipeline
Patients
Careers
Investors & News
Context Therapeutics
About
Pipeline
Patients
Careers
Investors & News
About
Pipeline
Patients
Careers
Investors & News

News

Publications Martin Lehr 11/7/25 Publications Martin Lehr 11/7/25

CT-202: a Dual pH-dependent Nectin-4xCD3 Bispecific T Cell Engager

Stanley A. Roberts, Kelly Byrnes-Blake, Heather Ansorge, Eric Butz

Society for Immunotherapy of Cancer (SITC) I Annual Meeting I Abstract 963 I November 7-9, 2025

Read More

About Us
Leadership
Partnering
Contact Us

Pipeline
CTIM-76
CT-95
CT-202

Patients
Clinical Trials
Investigator Led Trials
Access Policy

Investors & Media
News
Publications

Careers
Open Positions

Privacy Policy          Terms of Use

© Context Therapeutics Inc. 2025  |  All Rights Reserved